164 related articles for article (PubMed ID: 10821461)
1. Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris.
Fiorina P; Astorri E; Albertini R; Secchi A; Mello A; Lanfredini M; Craveri A; Olivetti G; Quaini F
J Clin Immunol; 2000 Mar; 20(2):101-6. PubMed ID: 10821461
[TBL] [Abstract][Full Text] [Related]
2. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
4. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.
Setsuta K; Seino Y; Ogawa T; Ohtsuka T; Seimiya K; Takano T
Circ J; 2004 Aug; 68(8):747-50. PubMed ID: 15277733
[TBL] [Abstract][Full Text] [Related]
5. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease.
Simon AD; Yazdani S; Wang W; Schwartz A; Rabbani LE
Clin Cardiol; 2001 Mar; 24(3):253-6. PubMed ID: 11288973
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of circulating soluble Fas and Fas ligand in patients with acute myocardial infarction.
Ohtsuka T; Hamada M; Sasaki O; Suzuki M; Hara Y; Shigematsu Y; Ohtani T; Honda T; Hiwada K
Coron Artery Dis; 1999 Jun; 10(4):221-5. PubMed ID: 10376200
[TBL] [Abstract][Full Text] [Related]
8. Acute T-cell activation is detectable in unstable angina.
Neri Serneri GG; Prisco D; Martini F; Gori AM; Brunelli T; Poggesi L; Rostagno C; Gensini GF; Abbate R
Circulation; 1997 Apr; 95(7):1806-12. PubMed ID: 9107167
[TBL] [Abstract][Full Text] [Related]
9. [Circulating adhesion molecules (cICAM-1, lcVCAM-1) in patients with suspected inflammatory heart muscle disease].
Klein RM; Breuer R; Mundhenke M; Schwartzkopff B; Strauer BE
Z Kardiol; 1998 Feb; 87(2):84-93. PubMed ID: 9556870
[TBL] [Abstract][Full Text] [Related]
10. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble form of Fas molecule in patients with congestive heart failure.
Okuyama M; Yamaguchi S; Nozaki N; Yamaoka M; Shirakabe M; Tomoike H
Am J Cardiol; 1997 Jun; 79(12):1698-701. PubMed ID: 9202370
[TBL] [Abstract][Full Text] [Related]
12. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.
Aukrust P; Müller F; Ueland T; Berget T; Aaser E; Brunsvig A; Solum NO; Forfang K; Frøland SS; Gullestad L
Circulation; 1999 Aug; 100(6):614-20. PubMed ID: 10441098
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating soluble form of Fas in patients with dilated cardiomyopathy.
Kawakami H; Shigematsu Y; Ohtsuka T; Okayama H; Hayashi Y; Hara Y; Kodama K; Hamada M; Hiwada K
Jpn Circ J; 1998 Dec; 62(12):873-6. PubMed ID: 9890197
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis.
Sano H; Asano K; Minatoguchi S; Hiraoka J; Fujisawa K; Nishigaki K; Yasuda N; Kumada H; Takemura M; Ohashi H; Seishima M; Fujiwara T; Fujiwara H
Nephron; 1998 Oct; 80(2):153-61. PubMed ID: 9736812
[TBL] [Abstract][Full Text] [Related]
16. Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking.
Atalar E; Haznedaroglu IC; Kilic H; Ozer N; Coskun S; Ozturk E; Aksoyek S; Ovunc K; Kirazli S; Ozmen F
Platelets; 2005 Sep; 16(6):329-33. PubMed ID: 16194862
[TBL] [Abstract][Full Text] [Related]
17. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
Lenzlinger PM; Marx A; Trentz O; Kossmann T; Morganti-Kossmann MC
J Neuroimmunol; 2002 Jan; 122(1-2):167-74. PubMed ID: 11777556
[TBL] [Abstract][Full Text] [Related]
18. The complement system in ischemic heart disease.
Yasuda M; Takeuchi K; Hiruma M; Iida H; Tahara A; Itagane H; Toda I; Akioka K; Teragaki M; Oku H
Circulation; 1990 Jan; 81(1):156-63. PubMed ID: 2297823
[TBL] [Abstract][Full Text] [Related]
19. Serum Fas/FasL levels in dependence on clinical presentations of coronary disease and their relationship with risk factors.
Ristić T; Djordjević VB; Deljanin-Ilić M; Cosić V; Kundalić S
Vojnosanit Pregl; 2010 Jul; 67(7):537-42. PubMed ID: 20707047
[TBL] [Abstract][Full Text] [Related]
20. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
